Serevent is the drug created by GlaxoSmithKline for the treatment of asthma. A recent study of Serevent and another Glaxo asthma product, Advair, found that both drugs could trigger fatal attacks in some patients. A safety monitoring board shut down the Serevent study once the heightened risk of death was discovered. Since then, the FDA has forced Glaxo to place a black box warning on Serevent and Advair, disclosing the significant risk of death on the packaging and in advertisements. A black box warning label is the most serious warning issued by the Federal Food and Drug Administration. As of December 2003, no such warning existed on product packaging or marketing material for Serevent.

Serevent is an aerosol spray used twice daily to open the bronchial airways, allowing asthma patients to breathe more easily. A very popular asthma medication, and widely used, the lack of a visible warning of potentially lethal side effects for users of Serevent is all the more disturbing.

If you or a loved one has been injured from taking Serevent, please submit the accompanying form. You may be entitled to monetary awards for your injury!